CompanyDrug

Merck’s Keytruda Under Priority Review for New Indication in Endometrial Carcinoma

CompanyDeals

Immune-Onc Therapeutics Partners with Roche for Phase Ib/II Study of IO-108 in Liver Cancer

CompanyDeals

Innovent Biologics Partners with ImmVirX to Launch Clinical Study Combining Tyvyt and IVX037

Company

Biogen Appoints Ding Weibo as Head of Asia-Pacific Region, Succeeding Francis Wan

CompanyDeals

Shenzhen Eureka Biotechnology Secures RMB 300 Million in Series B+ Funding for CGT Expansion

CompanyDrug

Mabwell Bioscience Receives FDA Green Light for B7-H3 Targeting ADC 7MW3711

CompanyDeals

BMS and Sichuan Biokin Commence Joint Development of EGFR/HER3-Targeted ADC

CompanyDeals

Everest Medicines Terminates Agreement with Providence Therapeutics, Retains mRNA Rights

CompanyDrug

Jacobio Pharma Gets CDE Green Light for Phase III Study Combining Gleevec Inhibitors in NSCLC

CompanyDrug

Neurophth Biotechnology Completes Enrollment and Dosing in US Clinical Study for ND4-LHON Gene Therapy

CompanyDeals

Biocytogen Pharmaceuticals Inks Antibody Evaluation Deal with Gilead Sciences

CompanyDeals

Evopoint Biosciences Secures USD 97.2 Million in Series E Financing to Boost Clinical Trials and Commercialization